Related to this topic: Leaflets | Support | Patient+ | UK Guidelines | Weblinks | Equipment | Books | Your Experience | Other resources | Glossaries
Print options:
Other options:
(what's this?)
PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Trachoma
In tropical countries 25 million people are blind from preventable causes and of those, trachoma is the most important. Trachoma is a very common chronic conjunctival infection caused by Chlamydia trachomatis, which is transmitted by flies or through close personal contact.
Other causes of preventable blindness include:
- Xerophthalmia, due to lack of vitamin A in the diet.
- Onchocerciasis, or river blindness, an infection of the skin by filarial larvae that may also affect the conjunctiva of the eye.
- Trachoma is the second commonest cause of blindness in the world and the commonest infective cause.
- It was once endemic in most countries but now is confined to Africa, Asia, the Middle East, and Aboriginal communities in Australia, as shown on the WHO map.1
- There is an estimate of 84 million people affected worldwide with 8 million visually impaired and 3.4 million blind.2
- There is no racial predilection, only a predilection for poverty and poor personal hygiene.
- Women are affected 2 to 4 times as often as men.
- In hyperendemic areas active disease is most common in pre-school children with prevalence rates as high as 60-90% although blindness does not occur until early adulthood or middle age.
- It is currently responsible for more than 3% of the world's blindness but the number keeps changing due to the effect of socio-economic development and current control programmes for this disease.
The infectious organism is Chlamydia trachomatis. Transmission is mostly between children and the women who care for them but blindness does not ensue until middle age. This accounts for the higher prevalence in women. Repeated episodes of infection cause chronic follicular conjunctival inflammation (active trachoma), leading on to the cicatrical stage of tarsal conjunctival scarring.
There are various stages of the disease that are described below and the references in this section link to pictures provided by the WHO:
- Follicular trachoma (Grade TF) produces active follicles on the upper tarsal conjunctiva. The peak age is in children age 3 to 5.3
- Inflammatory trachoma (Grade TI) causes thickening of the upper tarsal conjunctiva, which obscures more than half of the normal tarsal vessels and can produce significant conjunctival scarring and blindness. 4
- Trachomatous scarring (Grade TS) produces easily visible scarring in the upper tarsal conjunctiva.5
- Trichiasis (Grade TT) is when eyelashes touch the globe causing fibrosis and corneal opacification. Some vision can be restored with successful correction of trichiasis.6
- Corneal opacity (Grade CO) is defined as one that is easily visible and obscures at least part of the pupillary margin.7
Laboratory tests are not used in endemic areas where the clinical appearance is enough.
- Cell culture used to be the standard test but has been superseded by newer tests.
- In other areas polymerase chain reaction (PCR) and ligase chain reaction (LCR) have high sensitivity and specificity.
- Another new test is direct fluorescein-labeled monoclonal antibody (DFA) and enzyme immunoassay (EIA) of conjunctival smears.
- Giemsa cytology (the finding of intracytoplasmic inclusions) is technically demanding, has a high specificity but low sensitivity.
The World Health Organisation (WHO) has implemented a policy of prevention known by the mnemonic SAFE:8
- Surgery for trichiasis
- Antibiotics, especially azithromycin to eradicate infection
- Facial cleansing and attention to hygiene
- Environmental improvement
To turn to each:
- Eyelid surgery can prevent corneal scarring and blindness.
- Oral azithromycin is the antibiotic of choice and if a child is infected the whole family should be treated. Topical tetracycline and polymixin is as effective as oral azithromycin but the latter is a shorter course.9 Even a single dose of azithromycin causes a marked fall in prevalance and intensity of the disease in a mass programme and it was sustained for 2 years.10 A single dose of azithromycin is as effective as 6 weeks of topical tetracycline.
- Community based health promotion about facial cleansing and hygiene reduce the risk and severity of trachoma.11 Do not let flies walk over children's eyes.
- Environmental health involves personal hygiene as well as clean water and safe sewage disposal along with a reduction in flies.
Appropriate treatment of early disease gives an excellent prognosis. Severe disease may be stabilised but vision may not improve. Re-infection worsens the prognosis.
Document References
- World Health Organisation; World map showing distribution of Trachoma; 2005
- World Health Organisation; Priority eye diseases; Trachoma
- World Health Organisation; Trachoma grade TF
- World Health Organisation; Trachoma grade TF + TI
- World Health Organisation; Trachoma grade TS
- World Health Organisation; Trachoma grade TT
- World Health Organisation; Trachoma grade CO
- Bailey R, Leitman T; The SAFE strategy for the elimation of trachoma by 2020: Will it work?; Bulletin of the World health Organisation 2001; 79:233-6.
- Dawson CR, Schachter J, Sallam S, et al; A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. Clin Infect Dis. 1997 Mar;24(3):363-8. [abstract]
- Solomon AW, Holland MJ, Alexander ND, et al; Mass treatment with single-dose azithromycin for trachoma. N Engl J Med. 2004 Nov 4;351(19):1962-71. [abstract]
- West S, Munoz B, Lynch M, et al; Impact of face-washing on trachoma in Kongwa, Tanzania. Lancet. 1995 Jan 21;345(8943):155-8. [abstract]
Internet and Further Reading
- Solomon A; Trachoma; emedicine. January 2007.
- World Health Organisation; Priority eye diseases; Trachoma
DocID: 2887
Document Version: 20
DocRef: bgp889
Last Updated: 10 Apr 2007
Review Date: 9 Apr 2009
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicine
View patient experiences and discussions about this condition / medicine (1 there)Information leaflets related to this topic (^ top of page)
Chlamydia in Women
Dry EyesPatient Support related to this topic (^ top of page)
College of OptometristsMedical reference articles in PatientPlus related to this topic (^ top of page)
Congenital Infections in Neonates
Dry Eyes
Filariasis
Nematode (Roundworm) Skin Infestations
Nematodes (Roundworms)
OnchocerciasisUK guidelines related to this topic (^ top of page)
Guidelines on Dry EyesLinks to other selected websites related to this topic (^ top of page)
Chlamydial Conjunctivitis
Dry Eye
Onchocerciasis
River Blindness
TrachomaOther - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
A-Z of UK Guidelines
A-Z of Online Videos
Medline
Other good health sites
Medical equipment products related to this topic (^ top of page)

Books related to this topic (^ top of page)

Want to search some more? Use the Google Search box below to search our site.

Would you like to try our advanced on-line knowledge support system designed to provide professionals with relevant up to date information about recognition and management of disease or take the Mentor Challenge?
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
